Celecoxib in the treatment of depressio
- Conditions
- Major depressive disorder.Major Depressive episode
- Registration Number
- IRCT201405271556N58
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
1-Diagnosis of breast cancer from more than 100 days ago, 2-receiving chemotherapy, 3-score lower than 20 in Hamilton Rating Scale for depression 4-Mild to moderate major depressive disorder based on DSM-V 5- age between 18 to 60 years old, 6-copmplain of pain
Exclusion criteria: 1-receiving antidepressants during the last month, 2-receiving ECT during the last two months, 3-history of cardiovascular disease, 4-pregnant and nursing women, 5-Thyroid disease, 6-Psychotic disorder, 7-other psychiatric disorders
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of depression. Timepoint: Baseline and weeks 1-3-6 after beginig of treatment. Method of measurement: by Hamiltion Depression Rating Scale 17-Item.
- Secondary Outcome Measures
Name Time Method